AVNS Stock Analysis: Buy, Sell, or Hold?
AVNS - Avanos Medical, Inc.
$14.09
0.08 (0.57%)
▲
5d:
+2.1%
30d:
+0.71%
90d:
+24.69%
BUY
MODERATE Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 05, 2026
Get Alerted When AVNS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: AVNS shows positive signals but monitor for confirmation. Market pricing in 3.5% decline. Moderate conviction.
💡 BUY OPPORTUNITY: AVNS shows positive signals but monitor for confirmation. Market pricing in 3.5% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$30.43
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$18.89
25.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AVNS is currently trading at $14.09, which is considered slightly high relative to its 30-day fair value range of $13.30 to $14.20. The stock's valuation (Forward PE: 11.3) is in line with its historical norms (12.5). Remarkably, the market is currently pricing in an annual earnings decline of 3.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, AVNS is in a strong uptrend. The price is approaching resistance at $14.25. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AVNS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, AVNS is in a strong uptrend. The price is approaching resistance at $14.25. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AVNS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$13.30 -
$14.20
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
71.4%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($14.00)
Fair Price Analysis
30-Day Fair Range
$13.30 -
$14.20
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$13.03
Resistance Level
$14.25
Current Trend
Strong Uptrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.27
Wall Street Target
$14.00
(-0.6%)
Revenue Growth (YoY)
0.7%
Earnings Growth (YoY)
-37.5%
Profit Margin
-10.4%
Valuation Discount vs History
-3.5% cheaper
PE vs Historical
11.3 vs 12.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.5%
(market-implied from PE analysis)
1-Year Target
$13.60
(-4%)
2-Year Target
$13.12
(-7%)
3-Year Target
$12.66
(-10%)
3-Yr Target (if PE normalizes)
(PE: 11→13)
$14.04
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 25.0%)
$54.57
(+287%)
Base:
(SPY PE: 11.3, Growth: 25.0%)
$27.52
(+95%)
Bear:
(PE: 9.6, Growth: 25.0%)
$23.39
(+66%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 11.3 to 12.5
Stabilization Target:
$15.62
(+10.9%)
PE Expansion Potential:
+10.9%
Share & Embed Analysis
Last updated: April 02, 2026 4:10 AM ET
Data refreshes hourly during market hours. Next update: 5:10 AM
Data refreshes hourly during market hours. Next update: 5:10 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AVNS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Kerr Holbrook
SELL
15000 shares
2025-11-18
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 63 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$96 | 56 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$93 | 65 BUY |
|
PEN
Penumbra Inc |
STRONG BUY
18 analysts |
$360 | 58 HOLD |
